BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29602696)

  • 1. Preoperative assessment of peritoneal carcinomatosis of colorectal origin.
    Dohan A; Hobeika C; Najah H; Pocard M; Rousset P; Eveno C
    J Visc Surg; 2018 Sep; 155(4):293-303. PubMed ID: 29602696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases.
    Dresen RC; De Vuysere S; De Keyzer F; Van Cutsem E; Prenen H; Vanslembrouck R; De Hertogh G; Wolthuis A; D'Hoore A; Vandecaveye V
    Cancer Imaging; 2019 Jan; 19(1):1. PubMed ID: 30616608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin.
    De Vos N; Goethals I; Ceelen W
    Acta Chir Belg; 2014; 114(6):370-5. PubMed ID: 26021680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
    Liberale G; Lecocq C; Garcia C; Muylle K; Covas A; Deleporte A; Hendlisz A; Bouazza F; El Nakadi I; Flamen P
    Anticancer Res; 2017 Feb; 37(2):929-934. PubMed ID: 28179354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted magnetic resonance imaging in peritoneal carcinomatosis from suspected ovarian cancer: Diagnostic performance in correlation with surgical findings.
    Garcia Prado J; González Hernando C; Varillas Delgado D; Saiz Martínez R; Bhosale P; Blazquez Sanchez J; Chiva L
    Eur J Radiol; 2019 Dec; 121():108696. PubMed ID: 31683251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: History, clinical applications, and implementation.
    Low RN; Barone RM; Rousset P
    Eur J Surg Oncol; 2021 Jan; 47(1):65-74. PubMed ID: 30852063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI.
    Klumpp BD; Schwenzer N; Aschoff P; Miller S; Kramer U; Claussen CD; Bruecher B; Koenigsrainer A; Pfannenberg C
    Abdom Imaging; 2013 Feb; 38(1):64-71. PubMed ID: 22476333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study.
    Cistaro A; Cucinotta M; Cassalia L; Priola A; Priola S; Pappalardo M; Coppolino P; De Simone M; Quartuccio N
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):232-7. PubMed ID: 26907833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative CT-based predictive factors for resectability and medium-term overall survival in patients with peritoneal carcinomatosis from colorectal cancer.
    Suzuki C; Wallgren H; Abraham-Nordling M; Palmer G
    Clin Radiol; 2018 Aug; 73(8):756.e11-756.e16. PubMed ID: 29678273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative assessment of splenic involvement in patients with peritoneal carcinomatosis with CT and MR imaging.
    Berthelin MA; Barral M; Eveno C; Rousset P; Dautry R; Pocard M; Soyer P; Dohan A
    Eur J Radiol; 2019 Jan; 110():60-65. PubMed ID: 30599874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitfalls and mimickers on (18)F-FDG-PET/CT in peritoneal carcinomatosis from colorectal cancer: An analysis from 37 patients.
    Audollent R; Eveno C; Dohan A; Sarda L; Jouvin I; Soyer P; Pocard M
    J Visc Surg; 2015 Nov; 152(5):285-91. PubMed ID: 26115889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    de Bree E; Koops W; Kröger R; van Ruth S; Verwaal VJ; Zoetmulder FA
    Eur J Surg Oncol; 2006 Feb; 32(1):65-71. PubMed ID: 16290055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [State-of-the-art imaging of peritoneal carcinomatosis].
    Pfannenberg C; Schwenzer NF; Bruecher BL
    Rofo; 2012 Mar; 184(3):205-13. PubMed ID: 22198834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
    Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
    Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative computed tomography does not predict resectability in peritoneal carcinomatosis.
    Rivard JD; Temple WJ; McConnell YJ; Sultan H; Mack LA
    Am J Surg; 2014 May; 207(5):760-4; discussion 764-5. PubMed ID: 24791641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resectability of Peritoneal Carcinomatosis: Learnings from a Prospective Cohort of 533 Consecutive Patients Selected for Cytoreductive Surgery.
    Mohkam K; Passot G; Cotte E; Bakrin N; Gilly FN; Ledochowski S; Bernard L; Valette PJ; Glehen O; Rousset P
    Ann Surg Oncol; 2016 Apr; 23(4):1261-70. PubMed ID: 26628435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of PET/CT in peritoneal carcinomatosis from colorectal cancer.
    Bamba Y; Itabashi M; Kameoka S
    Hepatogastroenterology; 2012; 59(117):1408-11. PubMed ID: 22094993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study.
    Esquivel J; Chua TC; Stojadinovic A; Melero JT; Levine EA; Gutman M; Howard R; Piso P; Nissan A; Gomez-Portilla A; Gonzalez-Bayon L; Gonzalez-Moreno S; Shen P; Stewart JH; Sugarbaker PH; Barone RM; Hoefer R; Morris DL; Sardi A; Sticca RP
    J Surg Oncol; 2010 Nov; 102(6):565-70. PubMed ID: 20976729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative assessment of peritoneal carcinomatosis in patients undergoing hyperthermic intraperitoneal chemotherapy following cytoreductive surgery.
    Pasqual EM; Bertozzi S; Bacchetti S; Londero AP; Basso SM; Santeufemia DA; Lo Re G; Lumachi F
    Anticancer Res; 2014 May; 34(5):2363-8. PubMed ID: 24778044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer.
    Lorimier G; Linot B; Paillocher N; Dupoiron D; Verrièle V; Wernert R; Hamy A; Capitain O
    Eur J Surg Oncol; 2017 Jan; 43(1):150-158. PubMed ID: 27839895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.